Companies / POINT Biopharma Global Inc.
POINT Biopharma Global Inc.
PNTRACACIK 1811764
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Bvf Partners L P/IL 10% owner | Sell Open-market sale | Common Stock, $0.0001 par value | $111.73M | -9.0M -100.00% | 0 | high |
| Dec 18, 2023 | Bvf Partners L P/IL 10% owner | Sell Open-market sale | Common Stock, $0.0001 par value | $90.77M | -7.3M -100.00% | 0 | high |
| Dec 18, 2023 | Bvf Partners L P/IL 10% owner | Sell Open-market sale | Common Stock, $0.0001 par value | $11.16M | -896K -100.00% | 0 | high |
| Jun 24, 2021 | Kolchinsky Peter CEO | Grant Grant or award | Common Stock | $8.89M | +889K | 889,218 | low |
| May 25, 2022 | Fleshner Neil E. Executive | Sell Open-market sale | Common Stock | $4.24M | -564K -15.73% | 3,023,045 | medium |
| Jun 29, 2021 | Kolchinsky Peter CEO | Grant Grant or award | Common Stock | $2.09M | +209K +23.52% | 1,098,318 | low |
| Jun 29, 2021 | Ra Capital Management, L.P. Director | Buy Open-market buy | Common Stock | $2.09M | +209K +23.52% | 1,098,318 | high |
| Nov 17, 2022 | Silber Allan C Executive | Buy Open-market buy | Common Stock | $165.6K | +28K +0.65% | 4,246,208 | medium |